PBMC-derived integration-free iPSCs line SDQLCHi039-A from a patient with X-linked agammaglobulinemia carrying a novel 9-bp in-frame deletion in BTK gene
In: Stem Cell Research, Jg. 51 (2021-03-01)
Online
unknown
Zugriff:
X-linked agammaglobulinemia (XLA, OMIM #300755) is one of the most common pediatric primary immunodeficiencies characterized by failure to produce mature B lymphocytes and hypogammaglobulinemia, caused by mutation of the gene encoding Bruton's tyrosine kinase (BTK, OMIM *300300), a key regulator in B-cell development. Patients suffering XLA are prone to recurrent bacterial infection. We established an induced pluripotent stem cells (iPSCs) line from a 3-year-5-month-old boy with XLA caused by a hemizygous in-frame 9-bp deletion in BTK (c.1530-1538delATACCTGGA, p.Y510_E513delEYLEinsE). The iPSCs was verified based on pluripotency markers, original gene mutation and demonstrated trilineage differentiation potential in vitro.
Titel: |
PBMC-derived integration-free iPSCs line SDQLCHi039-A from a patient with X-linked agammaglobulinemia carrying a novel 9-bp in-frame deletion in BTK gene
|
---|---|
Autor/in / Beteiligte Person: | Liu, Ning ; Lv, Yuqiang ; Li, Yue ; Gai, Zhongtao ; Wang, Sulan ; Dong, Rui ; Liu, Yi ; Yang, Xiaomeng |
Link: | |
Zeitschrift: | Stem Cell Research, Jg. 51 (2021-03-01) |
Veröffentlichung: | Elsevier, 2021 |
Medientyp: | unknown |
ISSN: | 1873-5061 (print) |
Schlagwort: |
|
Sonstiges: |
|